Describing Patient With DME, Their Patient Journey and Disease Progression

Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05966753

Enrollment

221004

Registered

2023-08-01

Start date

2023-08-03

Completion date

2023-12-31

Last updated

2024-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Macular Edema

Brief summary

This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All patients ≥18 years, with a DME diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023)

Exclusion criteria

Patients without the information of laterality will be excluded.

Design outcomes

Primary

Measure	Time frame
Change in visual acuity	From January 2015 to April 2023
Progression to DME in the fellow eye	From January 2015 to April 2023
Initial treatment of DME	From January 2015 to April 2023
Central retinal thickness (CRT)	From January 2015 to April 2023

Countries

United States

Outcome results